Gene: PLAGL2
Official Full Name: PLAG1 like zinc finger 2provided by HGNC
Gene Summary: Pleiomorphic adenoma gene-like 2 is a zinc-finger protein that recognizes DNA and/or RNA. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36052 | PLAGL2 Knockout cell line (HeLa) | Human | PLAGL2 | 1:3~1:6 | Negative | Online Inquiry |
KO36053 | PLAGL2 Knockout cell line (HCT 116) | Human | PLAGL2 | 1:2~1:4 | Negative | Online Inquiry |
KO36054 | PLAGL2 Knockout cell line (HEK293) | Human | PLAGL2 | 1:3~1:6 | Negative | Online Inquiry |
KO36055 | PLAGL2 Knockout cell line (A549) | Human | PLAGL2 | 1:3~1:4 | Negative | Online Inquiry |
PLAGL2 Gene Knockout Cell Lines represent a cutting-edge tool in the field of molecular biology, specifically engineered to disrupt the PLAGL2 gene, which is known to be involved in various biological processes, including cell proliferation, differentiation, and response to stress. These cell lines provide researchers with a reliable system to investigate the functional implications of PLAGL2 in both normal and pathological contexts by facilitating the study of gene regulation and cellular pathways in a controlled environment.
The fundamental mechanism through which these knockout cell lines function lies in the CRISPR-Cas9 genome editing technology, which allows for precise, targeted gene disruption. This approach not only ensures the complete elimination of PLAGL2 activity but also allows for effective examination of phenotypic changes that arise from this genetic modification. As a result, scientists can elucidate the role of PLAGL2 in cancer biology, developmental processes, and metabolic disorders, leading to significant advancements in therapeutic strategies.
The scientific importance of PLAGL2 Gene Knockout Cell Lines is profound, as they provide versatile models for a multitude of applications ranging from basic research to translational medicine. In clinical settings, understanding the role of PLAGL2 can pave the way for novel diagnostic and therapeutic approaches to diseases associated with aberrant gene expression.
One of the unique selling points of these cell lines is their ease of use and reproducibility, compared to traditional knockdown approaches, which may produce variable results and often rely on transient transfection methods. Moreover, researchers benefit from the rigorous validation of these cell lines, ensuring consistency and reliability in experimental outcomes.
For researchers and clinicians, investing in PLAGL2 Gene Knockout Cell Lines is invaluable, as they enable precise investigations into gene function and provide a solid foundation for the development of targeted therapies. Our company prides itself on its expertise in producing high-quality biological products and resources for the scientific community, ensuring that you have access to the best tools for your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.